PDB Short entry for 5TD4 HEADER HYDROLASE 16-SEP-16 5TD4 TITLE STARCH BINDING SITES ON THE HUMAN PANCREATIC ALPHA AMYLASE D300N TITLE 2 VARIANT COMPLEXED WITH AN OCTAOSE SUBSTRATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANCREATIC ALPHA-AMYLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 16-511; COMPND 5 SYNONYM: PA,1,4-ALPHA-D-GLUCAN GLUCANOHYDROLASE; COMPND 6 EC: 3.2.1.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREAS; SOURCE 6 GENE: AMY2A; SOURCE 7 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS AMYLASE, DIABETES, OBESITY, GLUCOSYL HYDROLASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.CANER,G.D.BRAYER REVDAT 5 04-OCT-23 5TD4 1 HETSYN REVDAT 4 29-JUL-20 5TD4 1 COMPND REMARK HET HETNAM REVDAT 4 2 1 HETSYN FORMUL LINK SITE REVDAT 4 3 1 ATOM REVDAT 3 08-JAN-20 5TD4 1 JRNL REMARK SEQRES REVDAT 2 09-NOV-16 5TD4 1 JRNL REVDAT 1 02-NOV-16 5TD4 0 JRNL AUTH X.ZHANG,S.CANER,E.KWAN,C.LI,G.D.BRAYER,S.G.WITHERS JRNL TITL EVALUATION OF THE SIGNIFICANCE OF STARCH SURFACE BINDING JRNL TITL 2 SITES ON HUMAN PANCREATIC ALPHA-AMYLASE. JRNL REF BIOCHEMISTRY V. 55 6000 2016 JRNL REFN ISSN 0006-2960 JRNL PMID 27756128 JRNL DOI 10.1021/ACS.BIOCHEM.6B00992 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 3 NUMBER OF REFLECTIONS : 21229 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1062 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.4822 - 4.5978 0.94 2831 149 0.1423 0.1617 REMARK 3 2 4.5978 - 3.6503 0.87 2187 116 0.1246 0.1439 REMARK 3 3 3.6503 - 3.1891 0.83 2336 123 0.1570 0.2064 REMARK 3 4 3.1891 - 2.8977 0.99 2791 146 0.1678 0.2025 REMARK 3 5 2.8977 - 2.6900 0.99 2378 126 0.1659 0.2656 REMARK 3 6 2.6900 - 2.5315 0.99 2127 111 0.1595 0.1643 REMARK 3 7 2.5315 - 2.4047 1.00 2761 146 0.1641 0.2321 REMARK 3 8 2.4047 - 2.3000 1.00 2756 145 0.1663 0.2285 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4330 REMARK 3 ANGLE : 1.109 5919 REMARK 3 CHIRALITY : 0.064 666 REMARK 3 PLANARITY : 0.006 731 REMARK 3 DIHEDRAL : 13.259 2354 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TD4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000224031. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976067 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21229 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.299 REMARK 200 RESOLUTION RANGE LOW (A) : 38.464 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.8 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.04789 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.130 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4X9Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MPD 50-58%, 0.1M SODIUM CACODYLATE. REMARK 280 AFTER CRYSTAL REACHED FULL SIZE THEY WERE SOAKED IN 200MM REMARK 280 OCTAOSE FOR 24H PRIOR TO DATA COLLECTION, AND THEN INFUSED WITH REMARK 280 A FURTHER ALIQUOT OF OCTAOSE JUST BEFORE FREEZING THE COMPLEXED REMARK 280 CRYSTAL IN LIQUID NITROGEN FOR USE IN X-RAY DIFFRACTION REMARK 280 ANALYSES., PH 7.5, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.10500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.69000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.82000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.69000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.10500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.82000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 31 -57.53 -140.15 REMARK 500 MET A 102 -144.25 -101.65 REMARK 500 ASN A 137 31.50 -99.54 REMARK 500 THR A 163 46.28 31.07 REMARK 500 ASP A 317 59.74 -105.22 REMARK 500 SER A 414 -103.31 -135.17 REMARK 500 ASN A 459 77.91 45.92 REMARK 500 PRO A 486 40.66 -85.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 507 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 100 OD1 REMARK 620 2 ARG A 158 O 154.3 REMARK 620 3 ASP A 167 OD1 87.2 114.0 REMARK 620 4 ASP A 167 OD2 128.4 77.3 50.5 REMARK 620 5 HIS A 201 O 72.5 81.9 140.5 159.0 REMARK 620 6 HOH A 617 O 103.2 70.7 75.4 93.9 76.7 REMARK 620 7 HOH A 620 O 71.0 125.6 77.7 72.0 123.7 152.8 REMARK 620 8 HOH A 672 O 101.4 74.5 134.6 93.2 83.5 141.9 63.8 REMARK 620 N 1 2 3 4 5 6 7 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X9Y RELATED DB: PDB REMARK 900 4X9Y CONTAINS THE WILD TYPE PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 1CPU RELATED DB: PDB REMARK 900 1CPU CONTAINS THE WILD TYPE PROTEIN COMPLEXED WITH ACARBOSE REMARK 900 RELATED ID: 4W93 RELATED DB: PDB REMARK 900 4W93 CONTAINS THE WILD TYPE PROTEIN COMPLEXED WITH MONTBRETIN A REMARK 900 RELATED ID: 5KEZ RELATED DB: PDB REMARK 900 5KEZ CONTAINS THE WILD TYPE PROTEIN COMPLEXED WITH PIHA DBREF 5TD4 A 1 496 UNP P04746 AMYP_HUMAN 16 511 SEQADV 5TD4 ASN A 300 UNP P04746 ASP 315 ENGINEERED MUTATION SEQRES 1 A 496 PCA TYR SER PRO ASN THR GLN GLN GLY ARG THR SER ILE SEQRES 2 A 496 VAL HIS LEU PHE GLU TRP ARG TRP VAL ASP ILE ALA LEU SEQRES 3 A 496 GLU CYS GLU ARG TYR LEU ALA PRO LYS GLY PHE GLY GLY SEQRES 4 A 496 VAL GLN VAL SER PRO PRO ASN GLU ASN VAL ALA ILE TYR SEQRES 5 A 496 ASN PRO PHE ARG PRO TRP TRP GLU ARG TYR GLN PRO VAL SEQRES 6 A 496 SER TYR LYS LEU CYS THR ARG SER GLY ASN GLU ASP GLU SEQRES 7 A 496 PHE ARG ASN MET VAL THR ARG CYS ASN ASN VAL GLY VAL SEQRES 8 A 496 ARG ILE TYR VAL ASP ALA VAL ILE ASN HIS MET CYS GLY SEQRES 9 A 496 ASN ALA VAL SER ALA GLY THR SER SER THR CYS GLY SER SEQRES 10 A 496 TYR PHE ASN PRO GLY SER ARG ASP PHE PRO ALA VAL PRO SEQRES 11 A 496 TYR SER GLY TRP ASP PHE ASN ASP GLY LYS CYS LYS THR SEQRES 12 A 496 GLY SER GLY ASP ILE GLU ASN TYR ASN ASP ALA THR GLN SEQRES 13 A 496 VAL ARG ASP CYS ARG LEU THR GLY LEU LEU ASP LEU ALA SEQRES 14 A 496 LEU GLU LYS ASP TYR VAL ARG SER LYS ILE ALA GLU TYR SEQRES 15 A 496 MET ASN HIS LEU ILE ASP ILE GLY VAL ALA GLY PHE ARG SEQRES 16 A 496 LEU ASP ALA SER LYS HIS MET TRP PRO GLY ASP ILE LYS SEQRES 17 A 496 ALA ILE LEU ASP LYS LEU HIS ASN LEU ASN SER ASN TRP SEQRES 18 A 496 PHE PRO ALA GLY SER LYS PRO PHE ILE TYR GLN GLU VAL SEQRES 19 A 496 ILE ASP LEU GLY GLY GLU PRO ILE LYS SER SER ASP TYR SEQRES 20 A 496 PHE GLY ASN GLY ARG VAL THR GLU PHE LYS TYR GLY ALA SEQRES 21 A 496 LYS LEU GLY THR VAL ILE ARG LYS TRP ASN GLY GLU LYS SEQRES 22 A 496 MET SER TYR LEU LYS ASN TRP GLY GLU GLY TRP GLY PHE SEQRES 23 A 496 VAL PRO SER ASP ARG ALA LEU VAL PHE VAL ASP ASN HIS SEQRES 24 A 496 ASN ASN GLN ARG GLY HIS GLY ALA GLY GLY ALA SER ILE SEQRES 25 A 496 LEU THR PHE TRP ASP ALA ARG LEU TYR LYS MET ALA VAL SEQRES 26 A 496 GLY PHE MET LEU ALA HIS PRO TYR GLY PHE THR ARG VAL SEQRES 27 A 496 MET SER SER TYR ARG TRP PRO ARG GLN PHE GLN ASN GLY SEQRES 28 A 496 ASN ASP VAL ASN ASP TRP VAL GLY PRO PRO ASN ASN ASN SEQRES 29 A 496 GLY VAL ILE LYS GLU VAL THR ILE ASN PRO ASP THR THR SEQRES 30 A 496 CYS GLY ASN ASP TRP VAL CYS GLU HIS ARG TRP ARG GLN SEQRES 31 A 496 ILE ARG ASN MET VAL ILE PHE ARG ASN VAL VAL ASP GLY SEQRES 32 A 496 GLN PRO PHE THR ASN TRP TYR ASP ASN GLY SER ASN GLN SEQRES 33 A 496 VAL ALA PHE GLY ARG GLY ASN ARG GLY PHE ILE VAL PHE SEQRES 34 A 496 ASN ASN ASP ASP TRP SER PHE SER LEU THR LEU GLN THR SEQRES 35 A 496 GLY LEU PRO ALA GLY THR TYR CYS ASP VAL ILE SER GLY SEQRES 36 A 496 ASP LYS ILE ASN GLY ASN CYS THR GLY ILE LYS ILE TYR SEQRES 37 A 496 VAL SER ASP ASP GLY LYS ALA HIS PHE SER ILE SER ASN SEQRES 38 A 496 SER ALA GLU ASP PRO PHE ILE ALA ILE HIS ALA GLU SER SEQRES 39 A 496 LYS LEU MODRES 5TD4 PCA A 1 GLN MODIFIED RESIDUE HET PCA A 1 8 HET GLC B 1 12 HET GLC B 2 11 HET GLC B 3 11 HET GLC B 4 11 HET GLC C 1 12 HET GLC C 2 11 HET GLC C 3 11 HET GLC C 4 11 HET GLC D 1 12 HET GLC D 2 11 HET GLC D 3 11 HET GLC D 4 11 HET GLC D 5 11 HET GLC D 6 11 HET GLC E 1 12 HET GLC E 2 11 HET GLC E 3 11 HET GLC E 4 11 HET GLC E 5 11 HET GLC E 6 11 HET GLC F 1 12 HET GLC F 2 11 HET CL A 501 1 HET CA A 507 1 HETNAM PCA PYROGLUTAMIC ACID HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM CA CALCIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 1 PCA C5 H7 N O3 FORMUL 2 GLC 22(C6 H12 O6) FORMUL 7 CL CL 1- FORMUL 8 CA CA 2+ FORMUL 9 HOH *157(H2 O) HELIX 1 AA1 ARG A 20 TYR A 31 1 12 HELIX 2 AA2 PRO A 57 GLN A 63 5 7 HELIX 3 AA3 ASN A 75 VAL A 89 1 15 HELIX 4 AA4 SER A 132 PHE A 136 5 5 HELIX 5 AA5 ASP A 153 CYS A 160 1 8 HELIX 6 AA6 ARG A 161 THR A 163 5 3 HELIX 7 AA7 LYS A 172 GLY A 190 1 19 HELIX 8 AA8 ALA A 198 MET A 202 5 5 HELIX 9 AA9 TRP A 203 LYS A 213 1 11 HELIX 10 AB1 LYS A 243 PHE A 248 5 6 HELIX 11 AB2 PHE A 256 ARG A 267 1 12 HELIX 12 AB3 LYS A 273 TRP A 280 5 8 HELIX 13 AB4 GLY A 281 GLY A 285 5 5 HELIX 14 AB5 PRO A 288 ASP A 290 5 3 HELIX 15 AB6 ASN A 300 GLY A 304 5 5 HELIX 16 AB7 GLY A 308 ILE A 312 5 5 HELIX 17 AB8 THR A 314 TRP A 316 5 3 HELIX 18 AB9 ASP A 317 HIS A 331 1 15 HELIX 19 AC1 CYS A 384 ARG A 387 5 4 HELIX 20 AC2 TRP A 388 VAL A 401 1 14 HELIX 21 AC3 GLU A 493 LYS A 495 5 3 SHEET 1 AA1 9 SER A 12 LEU A 16 0 SHEET 2 AA1 9 GLY A 39 VAL A 42 1 O GLY A 39 N VAL A 14 SHEET 3 AA1 9 ARG A 92 ALA A 97 1 O TYR A 94 N VAL A 40 SHEET 4 AA1 9 GLY A 193 LEU A 196 1 O ARG A 195 N ALA A 97 SHEET 5 AA1 9 PHE A 229 GLN A 232 1 O PHE A 229 N PHE A 194 SHEET 6 AA1 9 ARG A 252 THR A 254 1 O ARG A 252 N GLN A 232 SHEET 7 AA1 9 ALA A 292 VAL A 294 1 O LEU A 293 N VAL A 253 SHEET 8 AA1 9 PHE A 335 SER A 340 1 O PHE A 335 N VAL A 294 SHEET 9 AA1 9 SER A 12 LEU A 16 1 N ILE A 13 O VAL A 338 SHEET 1 AA2 2 HIS A 101 GLY A 104 0 SHEET 2 AA2 2 LEU A 165 ASP A 167 -1 O LEU A 166 N CYS A 103 SHEET 1 AA3 2 PHE A 348 GLN A 349 0 SHEET 2 AA3 2 ASN A 352 ASP A 353 -1 O ASN A 352 N GLN A 349 SHEET 1 AA4 2 ASN A 362 ASN A 363 0 SHEET 2 AA4 2 VAL A 366 ILE A 367 -1 O VAL A 366 N ASN A 363 SHEET 1 AA5 4 PHE A 406 ASP A 411 0 SHEET 2 AA5 4 GLN A 416 ARG A 421 -1 O GLY A 420 N THR A 407 SHEET 3 AA5 4 GLY A 425 ASN A 430 -1 O PHE A 429 N VAL A 417 SHEET 4 AA5 4 PHE A 487 HIS A 491 -1 O ILE A 488 N VAL A 428 SHEET 1 AA6 2 PHE A 436 GLN A 441 0 SHEET 2 AA6 2 LYS A 474 ILE A 479 -1 O ILE A 479 N PHE A 436 SHEET 1 AA7 2 GLY A 447 CYS A 450 0 SHEET 2 AA7 2 LYS A 466 VAL A 469 -1 O ILE A 467 N TYR A 449 SHEET 1 AA8 2 LYS A 457 ILE A 458 0 SHEET 2 AA8 2 ASN A 461 CYS A 462 -1 O ASN A 461 N ILE A 458 SSBOND 1 CYS A 28 CYS A 86 1555 1555 2.05 SSBOND 2 CYS A 70 CYS A 115 1555 1555 2.30 SSBOND 3 CYS A 141 CYS A 160 1555 1555 2.05 SSBOND 4 CYS A 378 CYS A 384 1555 1555 2.04 SSBOND 5 CYS A 450 CYS A 462 1555 1555 2.02 LINK C PCA A 1 N TYR A 2 1555 1555 1.33 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.42 LINK O4 GLC B 2 C1 GLC B 3 1555 1555 1.43 LINK O4 GLC B 3 C1 GLC B 4 1555 1555 1.42 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.41 LINK O4 GLC C 2 C1 GLC C 3 1555 1555 1.44 LINK O4 GLC C 3 C1 GLC C 4 1555 1555 1.44 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK O4 GLC D 2 C1 GLC D 3 1555 1555 1.43 LINK O4 GLC D 3 C1 GLC D 4 1555 1555 1.40 LINK O4 GLC D 4 C1 GLC D 5 1555 1555 1.40 LINK O4 GLC D 5 C1 GLC D 6 1555 1555 1.44 LINK O4 GLC E 1 C1 GLC E 2 1555 1555 1.42 LINK O4 GLC E 2 C1 GLC E 3 1555 1555 1.45 LINK O4 GLC E 3 C1 GLC E 4 1555 1555 1.40 LINK O4 GLC E 4 C1 GLC E 5 1555 1555 1.39 LINK O4 GLC E 5 C1 GLC E 6 1555 1555 1.42 LINK O4 GLC F 1 C1 GLC F 2 1555 1555 1.40 LINK OD1 ASN A 100 CA CA A 507 1555 1555 2.51 LINK O ARG A 158 CA CA A 507 1555 1555 2.34 LINK OD1 ASP A 167 CA CA A 507 1555 1555 2.53 LINK OD2 ASP A 167 CA CA A 507 1555 1555 2.63 LINK O HIS A 201 CA CA A 507 1555 1555 2.39 LINK CA CA A 507 O HOH A 617 1555 1555 2.70 LINK CA CA A 507 O HOH A 620 1555 1555 2.51 LINK CA CA A 507 O HOH A 672 1555 1555 2.19 CISPEP 1 ASN A 53 PRO A 54 0 0.89 CISPEP 2 VAL A 129 PRO A 130 0 -5.43 CRYST1 52.210 73.640 135.380 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019153 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013580 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007387 0.00000 HETATM 1 N PCA A 1 12.207 -20.854 -0.755 1.00 17.36 N HETATM 2 CA PCA A 1 11.702 -20.330 -2.016 1.00 18.99 C HETATM 3 CB PCA A 1 11.955 -18.827 -2.103 1.00 19.13 C HETATM 4 CG PCA A 1 13.055 -18.523 -1.086 1.00 21.14 C HETATM 5 CD PCA A 1 13.028 -19.764 -0.228 1.00 23.02 C HETATM 6 OE PCA A 1 13.648 -19.832 0.834 1.00 23.58 O HETATM 7 C PCA A 1 12.391 -20.986 -3.220 1.00 20.54 C HETATM 8 O PCA A 1 11.950 -20.810 -4.348 1.00 18.99 O